Mangalam Drugs & Organics Limited has announced the release of pledged shares by its promoter, marking a significant development in the company's shareholding structure. The pharmaceutical company disclosed this transaction in compliance with SEBI regulations governing substantial acquisition of shares and takeovers.

Release of Pledged Shares

Promoter Aditya Ramniwas Dhoot released 89,000 pledged shares on March 16, 2026, representing 0.56% of the company's total share capital. The shares were previously pledged to M/s Famy care Private Ltd as security for debt obligations.

Current Shareholding Position

Following the release of pledged shares, Dhoot's overall holding in Mangalam Drugs & Organics Limited remains unchanged. His current shareholding details reflect his continued commitment to the company.

Regulatory Compliance

The disclosure was made on March 18, 2026, pursuant to Regulations 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company submitted the required documentation to both BSE Limited and National Stock Exchange of India Limited, where its shares are listed.

The transaction represents a routine corporate action involving the release of share pledges, which were originally created as security arrangements. Such disclosures ensure transparency in promoter shareholding patterns and compliance with regulatory requirements for listed companies in the pharmaceutical sector.

Shree Rasbihari Trading and Investments Private Limited, a promoter entity of Mangalam Drugs & Organics Limited , has announced the release of pledged shares worth 1.09% of the pharmaceutical company's total share capital. The disclosure was submitted to stock exchanges on March 18, 2026, in compliance with SEBI regulations.

Share Release Details

The promoter released 1,73,000 shares that were previously pledged as security for debt arrangements. These shares represent 1.09% of Mangalam Drugs & Organics Limited's total share capital and were encumbered in favor of M/s Famycare Private Ltd.

Promoter Shareholding Position

Following the release of pledged shares, Shree Rasbihari Trading maintains its overall shareholding position in the target company without any remaining encumbrances.

Regulatory Compliance

The disclosure was made pursuant to Regulations 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The notification was simultaneously submitted to both BSE Limited (Scrip Code: 532637) and National Stock Exchange of India Limited (Symbol: MANGALAM), where Mangalam Drugs & Organics Limited shares are listed.

Corporate Information

Shree Rasbihari Trading and Investments Private Limited operates under CIN U65990MH1981PTC024001 with its registered office located at Marine Drive, Mumbai. The disclosure was signed by Director Smita A. Dhoot (DIN: 01867999), who digitally authenticated the submission on March 18, 2026.

The release of these pledged shares indicates the completion of the underlying debt arrangement that necessitated the original encumbrance, providing the promoter with full flexibility over its entire shareholding in the pharmaceutical company.